Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2006-005817-36Phase 4Active
Phase 4 trial of insulin aspart, insulin glargine, human insulin and insulin isophane in diabetes mellitus type 1 (T1D) (2 arms), sponsored by Bellvitge University Hospital. Primary endpoints: HYPO score and Lability Index. Started May 2007; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2006-005817-36.